Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Manuel J Irarrázaval Ll is active.

Publication


Featured researches published by Manuel J Irarrázaval Ll.


Revista Medica De Chile | 2008

Mixoma cardiaco: Caracterización clínica, métodos diagnósticos y resultados alejados del tratamiento quirúrgico durante tres décadas de experiencia

Pedro Becker R; Alejandro Ramírez M; Ricardo Zalaquett S; Morán S; Manuel J Irarrázaval Ll; Claudio Arretz V; Samuel Córdova A; Pilar Arnaiz G

Background: Cardiac myxoma is the most common primary cardiac tumor. Aim: To evaluate clinical aspects, diagnostic methods and surgical outcomes in patients with cardiac myxoma. Patients and Methods: All patients who underwent surgical resection of a cardiac myxoma between January 1973 and December 2004 at our institution, were identified and their medical records and diagnostic data reviewed. Results: Thirty seven patients identified (24 women), with a median age of 54 years (range 2-74). The most common symptom was dyspnea (51%), followed by embolism (24%) and cardiac murmurs (16%). The diagnosis was made by echocardiogram in 84% of patients. The mean tumor size was 4.9 ± 1.3 cm. The tumor was located in the left atrium in 83% of the patients, right atrium in 8% and left ventricle in 3%. Two patients had multiple tumors. Surgical approach was transeptal in 51%, left atriotomy in 22%, combined transeptal and roof of the left atrium in 19% and right atriotomy in 8%. The tumor and its attachment base were excised in one piece. There were two operative deaths and five late deaths. The mean follow-up was 11.5 years. The 5, 10, 15 and 20 years survival was 89%, 83%, 75% and 64%, respectively. Two patients had recurrence (5.4%), at 2 and 25 years after surgery, respectively, and the recurrence free survival at 10 and 25 years was 97% and 73%, respectively. Conclusions: Dyspnea was the most common symptom and echocardiogram the main diagnostic method. Surgical treatment was highly effective, with low mortality and recurrence rate, with good long term survival (Rev Med Chile 2008; 136: 287-95). (Key words: Echocardiography; Heart neoplasms; Myxoma)


Revista Medica De Chile | 2007

Factores determinantes en la aparición de fibrilación auricular post-cirugía de revascularización miocárdica: Un estudio prospectivo

Ricardo Baeza; Bernardita Garayar P; Morán S; Ricardo Zalaquett S; Manuel J Irarrázaval Ll; Pedro Becker R; Paola Viviani G; Marcela Ferrada K; Ramón Corbalán H.

Background: Atrial fibrillation (AF) is a relevant complication after coronary artery bypass grafting (CABG). However there is controversy regarding possible contributing factors. Aim: To study the incidence of AF, its risk factors and its repercussion on hospital stay and charges, in patients undergoing CABG. Material and methods: We prospectively collected information from all patients undergoing CABG in our institution, including demographic, surgical and laboratory variables. Exclusion criteria were chronic AF, recent onset AF and patients who needed additional surgical procedures. The primary endpoint was the incidence of AF during the hospital stay. Secondary endpoints were hospital length of stay and hospital charges. Results: We included 250 patients aged 62±9 years (199 males) in the analysis. Incidence of AF was 22% (54 patients). Multivariable analysis showed that age (Odds Ratio (OR) =1.10), previous CABG (OR =9.39), previous use of ACE inhibitors (OR =3.28) and aortic clamp >57 minutes (OR =3.97) were significantly associated with an increased risk of postoperative AF. Previous use of beta-blockers was associated with risk reduction (OR =0.43). Patients who developed AF had a longer hospital stay (p <0.001) and higher hospital charges (p =0.003). Conclusion: AF is a frequent complication in patients undergoing CABG. Risk factors are age, time of aortic clamp, previous CABG and ACE inhibitors. Beta-blockers may prevent its occurrence. Furthermore, AF has a negative impact on both hospital stay and hospital charges (Rev Med Chile 2007; 135: 967-74).


Revista Medica De Chile | 2004

Cirugía valvular reparadora en endocarditis infecciosa

Ricardo Zalaquett S; Luis Garrido O; Francisca Casas R; Morán S; Manuel J Irarrázaval Ll; Pedro Becker R; Sandra Braun J; Samuel Córdova A; Gastón Chamorro S; Iván Godoy J; Fernando Yáñez D; Jaime Labarca L; Carlos Pérez C

Background: Valve replacement has been the treatment of choice for patients with valvular complications of infectious endocarditis (IE). However, excellent results with valve repair allowed it to become a new therapeutic alternative for these patients. Aim: To evaluate the results of valve repair in patients with valvular complications of IE. Patients and Methods: From January 1991 to December 2000, 14 patients with valvular complications of IE underwent valve repair. Mean age was 37.9 ± 14.9. Results: New York Heart Association (NYHA) class was 2.8 ± 0.9. IE was located in the aortic in 6 (42%), in the mitral valve in 4 (29%) and in both valves in 4 cases (29%). Surgical indication was hemodynamic in 50% of the cases, echocardiographic in 29% and septic in 21%. Five aortic valves were bicuspid, 3 mitral valves were myxomatous and the rest were normal. The most common septic lesions were vegetations and leaflet perforations. A total of 23 aortic and 21 mitral valve repair procedures were performed. There were no deaths. Only 1 patient had a surgical complication (renal failure and prolonged mechanical ventilation). Follow-up was 100% complete. There was not late mortality. One patient with bone marrow aplasia required reoperation for a new episode of IE 19 months later. At the end of the follow-up NYHA class was 1.3 ± 0.6 and echocardiography showed a mild or absence of valve regurgitation in most patients. Conclusions: Valve repair surgery in IE has good results, with advantages over valve replacement (Rev Med Chile 2004; 132: 307-15). (Key Words: Cardiovascular surgical procedures; Endocarditis, bacterial; Surgical procedures, operative)


Revista Medica De Chile | 2003

Resultados alejados de la cirugía reparadora de la insuficiencia mitral degenerativa

Ricardo Zalaquett S; Cristóbal Camplá C; Samuel Córdova A; Sandra Braun J; Gastón Chamorro S; Manuel J Irarrázaval Ll; Morán S; Pedro Becker R; Iván Godoy J; Fernando Yáñez D

Background: Mitral valve repair is probably the procedure of choice for the surgical treatment of degenerative mitral insufficiency. Aim: To evaluate the late results of mitral valve repair in degenerative mitral insufficiency. Patients and method: The records of 88 patients who underwent mitral valve repair for degenerative mitral insufficiency from December 1991 through June 2002 were reviewed. Mean age was 59.9 years (range 22 to 82). At least moderate mitral insufficiency was present in every patient. Mean left atrial diameter was 55 mm and mean end diastolic and end systolic left ventricular diameters were 61 and 37 mm respectively. Results: The most common underlying lesion was ruptured chordae tendineae (66%) and posterior leaflet prolapse (68%). The surgical procedure most frecuently performed was quadrilateral resection of the posterior leaflet (68%). A Carpentier-Edwards ring was placed in 97% of patients. An associated procedure was performed in 34%. Operative mortality was 2.3%. A complete follow up was obtained in 93% of cases with a mean of 54±36 months. Overall survival rate was 98% at one year, 88% at 5 and 82% at 10 years. Free of cardiac death rates were 94% at 5 and 89% at 10 years. Only 2 patients were reoperated during follow up, resulting in a 98% reoperation free rate follow up. Functional class improved in all patients at the end of follow up. Late echocardiographic evaluation showed absent or minimal mitral regurgitation in 83% and mild mitral regurgitation in 17%. Conclusion: Good late results have been obtained with mitral valve repair, avoiding the inconveniencies of prosthetic replacement. Therefore, mitral valve repair should be the procedure of choice to treat degenerative mitral insufficiency (Rev Med Chile 2003; 131: 1355-64). (Key Words: Mitral valve insufficiency)


Revista Medica De Chile | 2001

Tratamiento de la insuficiencia cardíaca avanzada mediante trasplante de corazón

Sergio Moran; Pablo Castro G; Ricardo Zalaquett S; Pedro Becker R; Bernardita Garayar P; Manuel J Irarrázaval Ll; orge Jalil M; Guillermo Lema F; Alejandro Fajuri N.; Osvaldo Pérez P; Alejandro Martínez S; Eugenio Marchant D.; Gastón Chamorro S

Background: Heart transplantation currently provides the most effective treatment for advanced heart failure. However, medical therapy for this condition has also improved, heart donors are scarce and the cost of the procedure is high. Therefore the indications and management of these patients need reevaluation. Aim: To analyze the results of 24 patients submitted to heart transplantation for end-stage heart failure needing repeated hospitalizations and i.v. inotropes for compensation. Patients and methods: The group was comprised by 21 men and 3 women with a mean age of 36.8 years, mean left ventricular ejection fraction 19±4.5%, mean systolic pulmonary artery pressure 48±13 mmHg (24-70) and mean pulmonary vascular resistance 2.6 Wood Units (1-5). Fourteen patients (58%) had a previous median sternotomy. Immunosupression did not include induction therapy and steroids were discontinued early. Results: Operative mortality was 4% at 30 days. Actuarial survival at one year was 90% and at 5 years 72%. Freedom from rejection at one year was 76% and at 5 years 50%. Freedom from infection was 70% at one year and 56.5% at five years. All patients with more than 3 months of follow-up were in functional class I. Conclusions: These results justify the proposed modifications for transplantation protocols (Rev Med Chile 2001; 129: 9-17).


Revista Medica De Chile | 2002

Experiencia de 36 años con marcapasos implantables: Un análisis histórico

Juan Dubernet M.; Gastón Chamorro S; Jorge A González M.; Alejandro Fajuri N.; Jorge Jalil M; Pablo Casanegra P; Gustavo Maturana B; Sergio Moran; Ricardo Zalaquett S; Manuel J Irarrázaval Ll; Jorge Urzúa U.; Rodríguez Ja; Sandra Braun J; Ramón Corbalán H.; Rolando González A.; Eugenio Marchant D.

Background: The implantation of pacemakers improves cardiac function and quality of life, in particular with dual chamber DDD and DDDR modes. Aim: To evaluate our clinical experience and results on pacemaker implantation, from 1963 to 1998. Material and methods: Computerized data collected from 2,445 consecutive paced patients was reviewed. A total of 3,554 operative procedures were performed, including 412 procedures for complications and 697 pacemaker replacement. Patient survival was determined from clinical records, inquiry to pacemaker manufacturers and death certificates from Servicio de Registro Civil e Identificacion de Chile (Chilean Civil and Identification Registry). Results: Use of dual chamber (DDD and DDDR) pacemakers increased progressively up to 74% from 1988 to 1998. Complication rate was 42% in the 1963-1976 study period, it decreased to 10.6% in the 1977-1987 study period, and to 5.6% by 1988-1998. Only two patients died during surgery in the study period (0.08%). In the 1977-1987 period, pacemakers lasted 10.6 years. Survival rates were 52% at ten years, 33% at 15 years, and 21% at 20 years, with a median survival of 11.7 years, and 7.24 years in patients over 80 years old. Conclusions: Transvenous permanent pacing can be accomplished today with a low complication rate, mainly due to better technology and surgical procedures (Rev Med Chile 2002; 130: 132-42)


Revista Medica De Chile | 2002

Cirugía de la insuficiencia mitral isquémica

Ricardo Zalaquett S; Luis Garrido O; Sergio Moran; Manuel J Irarrázaval Ll; Pedro Becker R; Gustavo Maturana B; Gastón Chamorro S; Sandra Braun J; Iván Godoy J; Samuel Córdova A

Background. Ischemic mitral regurgitation (IMR) is a severe condition which may be best treated by surgery, nowithstanding a relatively high mortality rate. Objectives. To evaluate the results of mitral valve replacement or repair in patients with IMR. Patients and methods. Retrospective review of the clinical records in 29 patients with IMR who were surgically treated from 1990 to 1999. They represent 8% of surgical procedures on the mitral valve. Results. Mean age was 67 ± 9 years. Surgery was performed urgently in 19 patients (66,5%). NYHA functional class was 3.4 ± 0.8. The mechanism of IMR was annular dilatation and spreading of papillary muscles in 18 patients, papillary muscle rupture in 9 and fibrosis in 2. Mitral valve replacement was performed in 14 patients and mitral valve repair in 15. Twenty four patients (83%) had concomitant myocardial revascularization. Overall surgical mortality was 24%; 26% for mitral replacement and 13% for mitral valve repair (p=0.215). On follow up of 26±33 months, one year survival was 76±0.8% and 5 years survival was 59±12%. Excluding in hospital mortality, survival was 100% at one year and 78±14% at 5 years. Functional class improved in all survivors, to 1.4±0.5. Late echocardiographic evaluation of patients with mitral valve repair showed absence of mitral regurgitation in 58%, 1+ MR in 17% and 2+ MR in 25%. Conclusion. In spite of a high perioperative mortality, surgery for IMR is a valuable procedure for patients with an otherwise highly lethal disease (Rev Med Chile 2002; 130: 9-16)


Revista Medica De Chile | 2001

Infección de prótesis de aorta ascendente: tratamiento con aseo quirúrgico, preservación de prótesis y transposición de colgajo muscular en dos casos

Ricardo Zalaquett S; Pedro Vidal Gh; Manuel J Irarrázaval Ll; Carlos Arroyo L.; Carlos Pérez C; Jaime Labarca L

Mediastinitis with graft infection is a serious complication of ascending aorta replacement. We report two cases of graft infection, treated with surgical cleaning, graft preservation and transposition of muscle flaps. A 62 years old male was admitted 34 days after an ascending aortic grafting due to a sternal dehiscence and mediastinitis. Antimicrobial treatment was started and a surgical cleaning performed, leaving an open sternotomy. Three days later, the thoracic cavity was closed with a rectus abdominis muscle flap. After 23 months of follow up, the patient is well and without evidence of infection. A 74 years old male was subjected to an aortic valve and ascending aorta replacement and a myocardial revascularization. In the postoperative period, the patient developed septic signs, and a purulent drainage. A CAT scan showed a liquid collection surrounding the aortic graft. On tW Sixteenth postoperative day, a surgical cleaning was performed and the thorax was closed with the pectoralis major muscle. After 10 months of follow up, the patient is in Good condition and without evidence of infection (AU)


Revista Medica De Chile | 2011

Resultados alejados de la cirugía reparadora de la insuficiencia mitral isquémica

Ricardo Zalaquett S; Emilio Flores A.; Fernando Cartajena de la M; Pablo Baechler S; Samuel Córdova A; Pedro Becker R; Morán S; Manuel J Irarrázaval Ll; Cecilia Muñoz C; Rodrigo González F

Background: The preferred treatment for ischemic mitral insufficiency is mitral valve repair with a prosthetic ring, because it does not deteriorate left ventricular function, allowing better immediate and long-term results. Aim: To assess long-term results of mitral annuloplasty with a prosthetic ring for ischemic mitral insufficiency. Patients and Methods: One hundred patients (68 men), with a mean age of 65.7 ± 8.6 years were included. They underwent a mitral annuloplasty with a prosthetic ring to treat ischemic mitral insufficiency, between February 1992 and May 2009. Fortyfour had a history of prior myocardial infarction and 46 had an evolving acute coronary syndrome. The inferior left ventricular wall was involved, exclusively or associated with an adjacent wall, in 72 cases. Coronary artery bypass grafts were performed in 92 patients and 32 required intra-aortic balloon pumping at some time during the peri-operative period. Results: Operative mortality was 10% (10 patients). During follow-up 30 patients died, at an average of 39 months after surgery (range: 3-142 months). Actuarial long-term survival rates at 1, 3 and 5 years were 79%, 72% and 64.5%, respectively. Trans esophageal echocardiogram performed in the operating room showed none or minimal residual mitral insufficiency in 96% of the cases. Echocardiographic follow-up was completed in 80% of the survivors; 79% of them had no or minimal mitral insufficiency. Only one patient was re-operated on due to severe mitral insufficiency and 4 required a permanent pacemaker. Conclusions: Considering the critical illness of these patients, good long-term results were observed after treatment of ischemic mitral regurgitation performing a mitral annuloplasty with a prosthetic ring.


Revista Medica De Chile | 2006

Reemplazo parcial o total del arco aórtico: Experiencia en 23 pacientes

Manuel J Irarrázaval Ll; Morán S; Ricardo Zalaquett S; Pedro Becker R; Cristian Baeza P; Jorge Urzúa U; Guillermo Lema F; Roberto Canessa B.; Gastón Chamorro S; Sandra Braun J; Samuel Córdova A; Bernardita Garayar P

Between 1988 and 2002, 23 patients wereoperated. Seventeen had aortic dissection (10 acute and 7 chronic), five had an atheroscleroticaneurysm and one had a traumatic lesion. Thirteen patients were subjected to a replacement of thearch plus ascending aorta, six to a replacement of the arch plus descending aorta and four to areplacement of the arch, ascending and descending aorta. Seven patients had previous operation ofthe thoracic aorta. Arterial perfusion was done via the femoral artery, axillary artery or a combinationof both. A hypothermic circulatory arrest was induced in 22; it was associated with cerebral retroperfusion alone in 8 patients, antegrade cerebral perfusion in 5; isolated or associated axillaryperfusion was used in five patients. In seven, procedures on the aortic or mitral valve, or coronaryartery operations were added. Operative mortality was 26%, 3 of the 8 patients operated as anemergency and 3 of 15 elective operations. There was no mortality among those without dissection andof 7 chronic dissections, one died. All patients were followed for an average of 45 months. Two patientsrequired reinterventions on the aorta and one for colon cancer. There was one late death of unknowncause. Postoperative complications were agitation, bleeding and temporary vocal cord dysfunction.

Collaboration


Dive into the Manuel J Irarrázaval Ll's collaboration.

Top Co-Authors

Avatar

Ricardo Zalaquett S

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Pedro Becker R

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Gastón Chamorro S

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Morán S

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Sandra Braun J

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Samuel Córdova A

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gustavo Maturana B

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Iván Godoy J

Pontifical Catholic University of Chile

View shared research outputs
Top Co-Authors

Avatar

Bernardita Garayar P

Pontifical Catholic University of Chile

View shared research outputs
Researchain Logo
Decentralizing Knowledge